Expression of mitogen-activated protein kinases in human renal dysplasia

Sayu Omori, Ryuji Fukuzawa, Mariko Hida, Midori Awazu

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background. We previously reported that the expression of mitogen-activated protein kinases (MAPKs) is developmentally regulated. Dysregulation of MAPKs may lead to kidney malformation. Thus, we investigated the expression of MAPKs in human renal dysplasia, one of the most common kidney malformations. Methods. Prenatal (gestational ages 20 to 36 weeks, N = 6) and postnatal (2 years old, N = 1) dysplastic kidneys, and normal kidneys (gestational ages 19 to 34 weeks, N = 4) were examined. Immunohistochemical studies were performed using antibodies against extracellular signal-regulated kinase (ERK), p38 MAPK (p38), c-Jun N-terminal kinase (JNK), phospho-MAPKs (P-MAPKs), and proliferating cell nuclear antigen (PCNA). Apoptosis was detected by the TUNEL method. Results. In dysplastic kidneys, proliferation was prominent in dysplastic tubules and also found in cyst epithelia. TUNEL staining was detected in dysplastic tubules and cysts, and occasionally in undifferentiated cells. p38 and anti-phospho-p38 (P-p38) were strongly expressed in dysplastic epithelia, but not detected in normal kidneys at any stage examined. On the other hand, JNK and P-JNK were positive in tubular epithelia of normal kidneys, whereas their expression was barely detectable in dysplastic tubules and cysts. ERK was expressed in all tubular segments, and P-ERK was detected in distal tubules and collecting ducts of normal kidneys. Dysplastic kidney epithelia stained exclusively positive for ERK and P-ERK. Conclusions. p38 is ectopically expressed, and JNK is down-regulated in dysplastic kidney epithelia. Furthermore, dysplastic epithelia are exclusively positive for ERK and P-ERK. Activated p38 and ERK may mediate hyperproliferation of dysplastic tubules resulting in cyst formation, whereas down-regulated JNK expression may be the cause or the result of an undifferentiated state of dysplastic epithelia.

Original languageEnglish
Pages (from-to)899-906
Number of pages8
JournalKidney International
Volume61
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

Mitogen-Activated Protein Kinases
Extracellular Signal-Regulated MAP Kinases
Kidney
Epithelium
Cysts
Phosphotransferases
In Situ Nick-End Labeling
p38 Mitogen-Activated Protein Kinases
Gestational Age
Collecting Kidney Tubules
JNK Mitogen-Activated Protein Kinases
Proliferating Cell Nuclear Antigen
Apoptosis
Staining and Labeling
Antibodies

Keywords

  • c-Jun N-terminal kinase
  • Development
  • Extracellular signal-regulated kinase
  • Kidney malformation
  • p38 mitogen-activated protein kinase

ASJC Scopus subject areas

  • Nephrology

Cite this

Expression of mitogen-activated protein kinases in human renal dysplasia. / Omori, Sayu; Fukuzawa, Ryuji; Hida, Mariko; Awazu, Midori.

In: Kidney International, Vol. 61, No. 3, 2002, p. 899-906.

Research output: Contribution to journalArticle

Omori, Sayu ; Fukuzawa, Ryuji ; Hida, Mariko ; Awazu, Midori. / Expression of mitogen-activated protein kinases in human renal dysplasia. In: Kidney International. 2002 ; Vol. 61, No. 3. pp. 899-906.
@article{f0ee313db3a84958abbf4d0d2844dd26,
title = "Expression of mitogen-activated protein kinases in human renal dysplasia",
abstract = "Background. We previously reported that the expression of mitogen-activated protein kinases (MAPKs) is developmentally regulated. Dysregulation of MAPKs may lead to kidney malformation. Thus, we investigated the expression of MAPKs in human renal dysplasia, one of the most common kidney malformations. Methods. Prenatal (gestational ages 20 to 36 weeks, N = 6) and postnatal (2 years old, N = 1) dysplastic kidneys, and normal kidneys (gestational ages 19 to 34 weeks, N = 4) were examined. Immunohistochemical studies were performed using antibodies against extracellular signal-regulated kinase (ERK), p38 MAPK (p38), c-Jun N-terminal kinase (JNK), phospho-MAPKs (P-MAPKs), and proliferating cell nuclear antigen (PCNA). Apoptosis was detected by the TUNEL method. Results. In dysplastic kidneys, proliferation was prominent in dysplastic tubules and also found in cyst epithelia. TUNEL staining was detected in dysplastic tubules and cysts, and occasionally in undifferentiated cells. p38 and anti-phospho-p38 (P-p38) were strongly expressed in dysplastic epithelia, but not detected in normal kidneys at any stage examined. On the other hand, JNK and P-JNK were positive in tubular epithelia of normal kidneys, whereas their expression was barely detectable in dysplastic tubules and cysts. ERK was expressed in all tubular segments, and P-ERK was detected in distal tubules and collecting ducts of normal kidneys. Dysplastic kidney epithelia stained exclusively positive for ERK and P-ERK. Conclusions. p38 is ectopically expressed, and JNK is down-regulated in dysplastic kidney epithelia. Furthermore, dysplastic epithelia are exclusively positive for ERK and P-ERK. Activated p38 and ERK may mediate hyperproliferation of dysplastic tubules resulting in cyst formation, whereas down-regulated JNK expression may be the cause or the result of an undifferentiated state of dysplastic epithelia.",
keywords = "c-Jun N-terminal kinase, Development, Extracellular signal-regulated kinase, Kidney malformation, p38 mitogen-activated protein kinase",
author = "Sayu Omori and Ryuji Fukuzawa and Mariko Hida and Midori Awazu",
year = "2002",
doi = "10.1046/j.1523-1755.2002.00196.x",
language = "English",
volume = "61",
pages = "899--906",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Expression of mitogen-activated protein kinases in human renal dysplasia

AU - Omori, Sayu

AU - Fukuzawa, Ryuji

AU - Hida, Mariko

AU - Awazu, Midori

PY - 2002

Y1 - 2002

N2 - Background. We previously reported that the expression of mitogen-activated protein kinases (MAPKs) is developmentally regulated. Dysregulation of MAPKs may lead to kidney malformation. Thus, we investigated the expression of MAPKs in human renal dysplasia, one of the most common kidney malformations. Methods. Prenatal (gestational ages 20 to 36 weeks, N = 6) and postnatal (2 years old, N = 1) dysplastic kidneys, and normal kidneys (gestational ages 19 to 34 weeks, N = 4) were examined. Immunohistochemical studies were performed using antibodies against extracellular signal-regulated kinase (ERK), p38 MAPK (p38), c-Jun N-terminal kinase (JNK), phospho-MAPKs (P-MAPKs), and proliferating cell nuclear antigen (PCNA). Apoptosis was detected by the TUNEL method. Results. In dysplastic kidneys, proliferation was prominent in dysplastic tubules and also found in cyst epithelia. TUNEL staining was detected in dysplastic tubules and cysts, and occasionally in undifferentiated cells. p38 and anti-phospho-p38 (P-p38) were strongly expressed in dysplastic epithelia, but not detected in normal kidneys at any stage examined. On the other hand, JNK and P-JNK were positive in tubular epithelia of normal kidneys, whereas their expression was barely detectable in dysplastic tubules and cysts. ERK was expressed in all tubular segments, and P-ERK was detected in distal tubules and collecting ducts of normal kidneys. Dysplastic kidney epithelia stained exclusively positive for ERK and P-ERK. Conclusions. p38 is ectopically expressed, and JNK is down-regulated in dysplastic kidney epithelia. Furthermore, dysplastic epithelia are exclusively positive for ERK and P-ERK. Activated p38 and ERK may mediate hyperproliferation of dysplastic tubules resulting in cyst formation, whereas down-regulated JNK expression may be the cause or the result of an undifferentiated state of dysplastic epithelia.

AB - Background. We previously reported that the expression of mitogen-activated protein kinases (MAPKs) is developmentally regulated. Dysregulation of MAPKs may lead to kidney malformation. Thus, we investigated the expression of MAPKs in human renal dysplasia, one of the most common kidney malformations. Methods. Prenatal (gestational ages 20 to 36 weeks, N = 6) and postnatal (2 years old, N = 1) dysplastic kidneys, and normal kidneys (gestational ages 19 to 34 weeks, N = 4) were examined. Immunohistochemical studies were performed using antibodies against extracellular signal-regulated kinase (ERK), p38 MAPK (p38), c-Jun N-terminal kinase (JNK), phospho-MAPKs (P-MAPKs), and proliferating cell nuclear antigen (PCNA). Apoptosis was detected by the TUNEL method. Results. In dysplastic kidneys, proliferation was prominent in dysplastic tubules and also found in cyst epithelia. TUNEL staining was detected in dysplastic tubules and cysts, and occasionally in undifferentiated cells. p38 and anti-phospho-p38 (P-p38) were strongly expressed in dysplastic epithelia, but not detected in normal kidneys at any stage examined. On the other hand, JNK and P-JNK were positive in tubular epithelia of normal kidneys, whereas their expression was barely detectable in dysplastic tubules and cysts. ERK was expressed in all tubular segments, and P-ERK was detected in distal tubules and collecting ducts of normal kidneys. Dysplastic kidney epithelia stained exclusively positive for ERK and P-ERK. Conclusions. p38 is ectopically expressed, and JNK is down-regulated in dysplastic kidney epithelia. Furthermore, dysplastic epithelia are exclusively positive for ERK and P-ERK. Activated p38 and ERK may mediate hyperproliferation of dysplastic tubules resulting in cyst formation, whereas down-regulated JNK expression may be the cause or the result of an undifferentiated state of dysplastic epithelia.

KW - c-Jun N-terminal kinase

KW - Development

KW - Extracellular signal-regulated kinase

KW - Kidney malformation

KW - p38 mitogen-activated protein kinase

UR - http://www.scopus.com/inward/record.url?scp=0036186941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036186941&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2002.00196.x

DO - 10.1046/j.1523-1755.2002.00196.x

M3 - Article

C2 - 11849444

AN - SCOPUS:0036186941

VL - 61

SP - 899

EP - 906

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -